Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care.
Reme
Silje Endresen
SE
Department of Psychological Medicine, King's College London, UK. silje.reme@uib.no
Kennedy
Tom
T
Jones
Roger
R
Darnley
Simon
S
Chalder
Trudie
T
D000293:Adolescent; D000328:Adult; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy / Q000523:psychology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010627:Phenethylamines / Q000627:therapeutic use*; D011320:Primary Health Care / Q000706:statistics & numerical data*; D011446:Prospective Studies; D016896:Treatment Outcome; D055815:Young Adult
D010276:Parasympatholytics; D010627:Phenethylamines; C005096:mebeverine